| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| WEXFORD CAPITAL LP | 10%+ Owner | $8,810,910 | 13 Mar 2024 | ||
| Arthur Amron | Director | $654,262 | 10 Nov 2025 | ||
| Oliver Spandow | Director | $614,573 | 10 Nov 2025 | ||
| Daron Evans | CEO Specialty Renal Products | $351,795 | 24 May 2021 | ||
| Andrew Astor | President, CEO & CFO, Director | $204,342 | 05 Mar 2022 | ||
| Robert R. Banks Jr. | President and CEO, Director | $156,870 | 14 May 2024 | ||
| Alisa Lask | Director | $109,167 | 01 Jan 2025 | ||
| Tom Gwydir | Director | $95,210 | 05 Jan 2023 | ||
| Wesley S. Lobo | Chief Marketing Officer | $77,461 | 16 Feb 2022 | ||
| Lisa Nettis | Director | $70,245 | 10 Nov 2025 | ||
| Joseph M. Harris | Director | $39,719 | 01 Jan 2025 | ||
| Judy Krandel | Chief Financial Officer | 27 Mar 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|